Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Dr.Mark Lawrence Chiu
Dr.Mark Lawrence Chiu



Tavotek Biotherapeutics

Dr. Mark Chiu has been in the pharmaceutical development industry for over 25 years and has rich experience in the R&D management of multinational pharmaceutical enterprises. He was the supervisor of multiple key R&D departments in Johnson & Johnson and Abbott, responsible for leading the early R&D of several blockbusting pharmaceutical products, for example Darzalex(Daratumumab)、Tremfya (Gesulkumab)、Remicade (Infliximab), Rybruvent (amivantamab), Teclistamab, Ciltacabtagene autoleucel, etc. before the founding of Tavotek Pharmaceuticals. Within only three years, he developed nine new molecular entities (NME) for Johnson & Johnson. He graduated with a BA Biophysics from the University of California Berkeley and Ph.D Biochemistry from the University of Illinois Urbana-Champaign.   He was a post-doctoral fellow working with two Nobel winners, was in study sections in European and United States Scientific Committees.